Interferon Alfa-2a in the Treatment of Subfoveal Choroidal Neovascularization
- 1 May 1993
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 115 (5), 563-568
- https://doi.org/10.1016/s0002-9394(14)71451-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Surgical Management of Subfoveal Choroidal NeovascularizationOphthalmology, 1992
- Surgical Excision of Subfoveal Neovascular Membranes in Age-related Macular DegenerationAmerican Journal of Ophthalmology, 1992
- Pathologic Features of Surgically Excised Subretinal Neovascular Membranes in Age-related Macular DegenerationAmerican Journal of Ophthalmology, 1991
- The InterferonsJAMA, 1991
- Surgical Removal of Subfoveal Neovascularization in the Presumed Ocular Histoplasmosis SyndromeAmerican Journal of Ophthalmology, 1991
- Treatment of childhood angiomatous diseases with recombinant interferon alfa-2aThe Journal of Pediatrics, 1991
- CLINICAL AND VIROLOGICAL EFFECTS OF HIGH-DOSE RECOMBINANT INTERFERON-α IN DISSEMINATED AIDS-RELATED KAPOSI'S SARCOMAThe Lancet, 1988
- Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron® A)Cancer, 1987
- Clinical overview of alpha interferon. Studies and future directionsCancer, 1987
- Inhibition of Cell Motility by InterferonScience, 1980